You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EATL

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T-Cell Lymphoma (PTCL NOS), Nodal Lymphomas of T Follicular Helper (TFH), Follicular T-cell Lymphoma (FTCL) Trial

Withdrawn
  • Peripheral T-Cell Lymphoma (PTCL NOS)
  • +8 more
  • (no location specified)
Mar 10, 2020

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting
  • LGLL - Large Granular Lymphocytic Leukemia
  • +13 more
  • Duarte, California
  • +9 more
Aug 9, 2022

Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Korea, Republic of, Spain, United States (Tipifarnib)

Completed
  • Relapsed or Refractory Peripheral T-Cell Lymphoma
  • Palo Alto, California
  • +12 more
Apr 26, 2021

Small Intestine Disease Trial (Double balloon enteroscopy)

Not yet recruiting
  • Small Intestine Disease
  • Double balloon enteroscopy
  • (no location specified)
Jul 20, 2022

Maternal Health, Child Health, Vaccination Trial in Dhaka (Impact of Mobile Phone Technology to Improve Health Nutrition and

Recruiting
  • Maternal Health
  • +3 more
  • Impact of Mobile Phone Technology to Improve Health Nutrition and Population (HNP) Service Utilization in Rural Bangladesh
  • Dhaka, Bangladesh
    Icddr,B
Feb 9, 2022

Celiac Disease Trial (AMG 714)

Available
  • Celiac Disease
  • AMG 714
  • (no location specified)
Jun 23, 2021

Peripheral T Cell Lymphoma, Relapse/Recurrence Trial in Belgium, France (Lacutamab, Gemcitabine, Oxaliplatine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Relapse/Recurrence
  • Antwerpen, Belgium
  • +38 more
Dec 6, 2021

Celiac Disease, Celiac Sprue, Gluten Enteropathy Trial in Rochester (Hu-Mik- Beta-1)

Completed
  • Celiac Disease
  • +3 more
  • Hu-Mik- Beta-1
  • Rochester, Minnesota
    Mayo Clinic, Rochester
Jan 16, 2020

ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified, Angioimmunoblastic T Cell

Unknown status
  • ALK-negative Anaplastic Large Cell Lymphoma
  • +5 more
  • Cyclophosphamide 750mg/m2
  • +8 more
  • Shanghai, Shanghai, China
    Ruijin hospital
Nov 10, 2017

Peripheral T Cell Lymphoma Trial in Guangzhou (chidamide, cyclophosphamide, liposomal doxorubicin)

Unknown status
  • Peripheral T Cell Lymphoma
  • Guangzhou, Guangdong, China
    Ru Feng
Jan 13, 2017